Disruptive healthcare technologies: ClearSky Medical Diagnostics

Today’s episode explores disruptive healthcare technologies in neurodegenerative diseases hosted by David Ferguson, Underwriting Development Manager in one of SCOR’s Innovation Teams. Our guest is Professor Stephen Smith, co-founder and director of ClearSky Medical Diagnostics and Professor of Electronic Engineering in the Department of Electronics at University of York. 1 in 4 people get a misdiagnosis in Parkinson’s disease which can lead to an overtreatment. Professor Smith highlights the importance of an accurate diagnosis in neurodegenerative diseases. ClearSky MD provides the PD-Monitor assisting specialists by measuring and identifying symptoms of Parkinson’s disease. Finding a tolerable balance between unpleasant side effects of the medication and its benefits is another focus. The LID-Monitor (Levodopa-induced dyskinesia) offers a safe and simple way of monitoring dyskinesia in the patient’s own home. ClearSky MD’s solutions empower patients to have the tools track their own conditions remotely with clear implications for how life & health insurance products are sold and monitored.